William (Bill) Tanner brings more than 25 years of experience to his role, combining deeps insights in life science corporate development, capital raising and investment banking. He most recently served as Co-founder and CFO of ImmunoGenesis, a clinical stage immuno-oncology company. He previously spent 20 years as a biotech and biopharma research analyst for leading healthcare investment banks including SG Cowen, Leerink Swann, Lazard Capital Markets, Guggenheim Securities and Vector Securities International. He has been involved in raising billions of dollars for public and private life science companies.
Bill holds a PhD in physiology from Texas A&M University and completed post-doctoral training at the Washington University School of Medicine in the Department of Cell Biology and Physiology and in the Department of Pathology, Center for Immunology. He also holds an MBA from the Olin School of Business at Washington University.
Select Achievements
- Co-founded immuno-oncology company ImmunoGenesis and secured capital to fund pre-clinical activities that led to a CPRIT grant and clinical readiness    Â
- As a research analyst, covered more than 100 biotech and biopharma companies across all market cap sizes
- Recipient of a National Research Service Award from the National Institutes of Health